China Pharma Holdings - 17 Year Stock Split History | CPHI
Stock split history for China Pharma Holdings since 2002. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
| China Pharma Holdings Annual Stock Splits |
|---|
| China Pharma Holdings Quarterly Stock Splits |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.016B | $0.012B |
| CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allergan (AGN) | Ireland | $46.453B | 8.36 |
| Teva Pharmaceutical Industries (TEVA) | Israel | $15.253B | 5.26 |
| Mylan (MYL) | United Kingdom | $13.642B | 5.77 |
| Bausch Health Cos (BHC) | Canada | $8.049B | 5.72 |
| Dr Reddy's Laboratories (RDY) | India | $6.783B | 27.05 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.934B | 17.94 |
| Mallinckrodt Public Limited Company (MNK) | United Kingdom | $1.520B | 2.47 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.979B | 90.48 |
| Homology Medicines (FIXX) | United States | $0.829B | 0.00 |
| Voyager Therapeutics (VYGR) | United States | $0.774B | 0.00 |
| CymaBay Therapeutics (CBAY) | United States | $0.756B | 0.00 |
| Progenics Pharmaceuticals (PGNX) | United States | $0.417B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.399B | 0.00 |
| Akorn (AKRX) | United States | $0.365B | 0.00 |
| Zynerba Pharmaceuticals (ZYNE) | United States | $0.211B | 0.00 |
| Adamas Pharmaceuticals (ADMS) | United States | $0.173B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.132B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.070B | 0.00 |
| Aquinox Pharmaceuticals (AQXP) | Canada | $0.064B | 0.00 |
| Agile Therapeutics (AGRX) | United States | $0.064B | 0.00 |
| Teligent (TLGT) | United States | $0.054B | 0.00 |
| Aevi Genomic Medicine (GNMX) | United States | $0.014B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.012B | 0.00 |
